[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"osteoperosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:osteoperosis":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100610764","the-investigation-of-the-effectiveness-of-virtual-reality-applications-in-postmenopausal-osteoporosis-patients-100610764",false,"NCT07231822","The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients","The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Postmenopausal women aged 50-75 years\n* Individuals diagnosed with osteoporosis based on Dual-Energy X-ray Absorptiometry (DEXA) measurement (T-score ≤ -2.5)\n* Having been in menopause for at least 1 year\n* Being able to walk independently (without the use of assistive devices)\n* Volunteering to participate in the study and having provided informed consent\n* Having adequate cognitive function (e.g., Mini Mental Test ≥ 24)\n\nExclusion Criteria:\n\n* Secondary osteoporosis diagnosis (e.g. endocrine, metabolic or drug-induced causes)\n* History of lower limb fracture or surgical intervention within the last 6 months\n* Individuals with severe cardiovascular, neurological, or musculoskeletal disorders\n* Individuals with vestibular or visual impairments that may affect balance\n* Intolerance to virtual reality applications (e.g., dizziness, nausea, etc.)\n* Individuals who have participated in a regular physiotherapy or exercise programme within the last 3 months",true,"ALL","40 Years","65 Years",{"count":21,"type":22},50,"ESTIMATED","INTERVENTIONAL",[25],"NA","Osteoporosis is a progressive disease characterised by a decrease in bone mass, deterioration in bone microarchitecture, and increased fragility. Etiologically, it is divided into two types: primary (postmenopausal and senile) and secondary. Postmenopausal women are particularly at high risk; it is seen in more than 80% of women over the age of 50 and in almost all individuals over the age of 75. With menopause, bone mineral density decreases, which negatively affects neuromuscular functions, leading to balance disorders, decreased walking speed, and an increased risk of falls. Falls are the primary cause of osteoporotic fractures and result in functional loss, morbidity, mortality, and increased healthcare costs. Exercise is effective in reducing bone loss; in recent years, therapeutic virtual reality and exercise games (exergames) have come to the fore. However, the literature on the effectiveness of these applications in postmenopausal osteoporosis patients is limited. The aim of this study is to investigate the effects of virtual reality applications on balance, quality of life, and fall risk and to compare them with a control group.",[28],"Osteoperosis",[30,31,32],"Postmenopausal osteoporosis","Virtual reality","balance","RECRUITING","2026-02-25",{"date":36,"type":37},"2026-02-27","ACTUAL",{"date":39,"type":37},"2025-11-20",{"date":41,"type":22},"2026-03-01",{"name":43,"class":44},"Kirsehir Ahi Evran Universitesi","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":17,"minAge":53,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":4,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":45},"100565653","monitoring-bleeding-of-patients-using-noac-anticoagulation-therapy-in-proximal-femoral-fracture-internal-fixation-surgery-without-waiting-we-measure-bleeding-in-surgery-and-the-levels-of-noac-drug-in-blood-we-will-try-to-compare-to-regular-pateints-later-100565653","NCT06644976","Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later","Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery","Inclusion Criteria:\n\nabove 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery\n\n\\-\n\nExclusion Criteria:\n\n* under 18 y.o\n* anti platelet therapy (aspirin is not included)\n* creatinine clearance under 50\n* active anti cancer therapy\n* ITP patients\n* non capable of making inform consent\n* patients which decide not to proceed with the expeirment","18 Years",{"count":55,"type":22},100,"OBSERVATIONAL","until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk",[28,59,60],"Femoral Neck Fractures","Anticoagulant Therapy","2024-10-14",{"date":63,"type":37},"2024-10-16",{"date":65,"type":37},"2024-08-20",{"date":67,"type":22},"2025-12",{"name":69,"class":44},"Meir Hospital, Kfar Saba, Israel"]